Skip to content
★ Sign in to follow
JG

Joyzyme Group Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$91.8MHealth Care

No insider purchase over the last 90 days. The latest, by Zhou Xunyong, was filed 12 Dec 2025.

Joyzyme Group Ltd.: what insiders have been doing

Joyzyme Group Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to HKEX. From 23 October 2025 to 23 October 2026, the disclosure feed for Joyzyme Group Ltd. logged 4 filings by 2 insiders.

Open-market activity splits into 2 purchases totalling €1,332 and 1 sale totalling €998; 1 insider sit on the buying side and 1 insider on the selling side. The net balance comes to €334 on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The largest single trade was a sale of €998 by Zhang Chunguang, published on 15 December 2025. On the buying side, the filings list 1 senior executive among the declarants.

The clock since the last published purchase (12 December 2025) now reads 331 days. Between a trade and the moment it shows up on HKEX, the median delay is 2 days. That lag is the time during which only the insider knows about the trade.

For context, the typical company on the same exchange (median of 1,315 companies) published 4 filings over the same period, against 4 filings here. Our records for Joyzyme Group Ltd. go back to 2020, with 6 purchases and 7 sales on the open market in total.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Source: insider filings from HKEX. Past trades are no guide to future returns.

Insider Decl.
15
Thresholds
n/a
Buy Volume
€1,332
6 ops. · all time
Sell Volume
€3M
7 ops. · all time

Who traded when

BuySale
Zhou Xunyong2 buys
Zhang Chunguang1 sale
Zhang Shuguang1 sale

Since the insiders bought

  • Filed 12 Dec 2025 · 331 days ago · €886
    -48.1%
    Entry HK$0.40 · Close 22 Oct 2026 HK$0.20

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 21,846 of 26,897 companies
29.7
score / 100
Value
23
Quality
37
FCF yld-4.2%
Earn yld-5.5%
EV/EBITDA·
ROE-10%
Gross mgn63%
Net mgn-18%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$0.18
Analyst consensus
·
Income statement
RevenueHK$28.3M
Gross profitHK$17.8M63% margin
EBITDA-HK$1.1M-4% margin
Net income-HK$5M-15.6% margin
Valuation
P/Book1.6x
Beta0.81
Balance sheet & cash
Market capHK$91.8M
Total debtHK$5M
Free Cash Flow-HK$3.9M
Debt / Equity16%
Profitability & ownership
ROE-10.0%
ROA-7.1%
% insiders51.9%
% institutions0.0%
Last declaration on 15 December 2025
Declarations15 total
  • ▼
    DirectorExecutives
    9,120 HKD11HKEX
    24,000 shares@ HK$0.381.8% of flowShareXHKGHKEX:DA20251215E00084
  • ▲
    DirectorExecutives
    8,064 HKD18HKEX
    64,000 shares@ HK$0.12666.5% of flowShareXHKGHKEX:DA20251212E00276
    Canonical exit: 11 Mar 2026 (T+90)
  • ●
    DirectorExecutives
    500,000 HKD19HKEX
    4,000,000 shares@ HK$0.12598.2% of flowShareXHKGHKEX:DA20251210E00050
  • ▲
    DirectorExecutives
    4,032 HKD14HKEX
    32,000 shares@ HK$0.12633.5% of flowShareXHKGHKEX:DA20251204E00154
    Canonical exit: 2 Mar 2026 (T+90)
  • ▼
    DirectorExecutives
    16M HKD18HKEX
    138,672,000 shares@ HK$0.117570.6% of flowShareXHKGHKEX:DA20250114E00485
  • ▼
    DirectorExecutives
    3M HKD12HKEX
    65,224,000 shares@ HK$0.049113.1% of flowShareXHKGHKEX:DA20240126E00260
  • ▼
    DirectorExecutives
    814,720 HKD11HKEX
    5,360,000 shares@ HK$0.1523.3% of flowShareXHKGHKEX:DA20240110E00609
  • ▼
    DirectorExecutives
    3M HKD12HKEX
    28,800,000 shares@ HK$0.1011.5% of flowShareXHKGHKEX:DA20231228E00469
  • ●
    DirectorExecutives
    500,000 HKD19HKEX
    4,000,000 shares@ HK$0.125100.0% of flowShareXHKGHKEX:DA20230818E00291
  • ▼
    DirectorExecutives
    252,000 HKD11HKEX
    1,400,000 shares@ HK$0.181.1% of flowShareXHKGHKEX:DA20230104E00617
  • ▼
    DirectorExecutives
    100,640 HKD11HKEX
    544,000 shares@ HK$0.1850.4% of flowShareXHKGHKEX:DA20221230E00571
  • ▲
    DirectorExecutives
    0HKEX
    4,000,000 sharesShareXHKGHKEX:DA20200429E00224
    Canonical exit: 27 Jul 2020 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    4,000,000 sharesShareXHKGHKEX:DA20200429E00226
    Canonical exit: 27 Jul 2020 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    4,000,000 sharesShareXHKGHKEX:DA20200429E00232
    Canonical exit: 27 Jul 2020 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    4,000,000 sharesShareXHKGHKEX:DA20200429E00222
    Canonical exit: 27 Jul 2020 (T+90)

15 of 15 declarations

About Joyzyme Group Ltd.

Joyzyme Group Ltd. is a company listed on the Hong Kong Stock Exchange, specializing in the development of enzymatic solutions. It focuses on innovation in the biotechnology sector.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations